Estithmar Holding brings EHL BIO the World’s Leading Stem Cell Therapy Center to KMC the Korean Medical Center in Lusail.

Elegancia Healthcare, a subsidiary of Estithmar Holding, has signed a Memorandum of Understanding (MoU) with the Korean EHL Bio Center to provide stem cell therapy at the soon to open Korean Medical Center in Lusail Boulevard, Through this exclusive partnership KMC will become the region’s exclusive provider of EHL bio expertise, products and cutting-edge stem cell technologies. Known globally for its pioneering achievements in stem cell research, EHL Bio has proven successes in biotechnology and healthcare innovation, developing revolutionary stem cell therapies, EHL Bio’s achievements include significant advancements in treating various diseases,enhancing regenerative medicine